CompletedNot Applicable

Transferrin Saturation and Asthenia in Hemochromatosis

France260 participantsStarted 2017-04-10

Plain-language summary

Observational study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Inclusion criteria: * homozygous C282Y ; * in the maintenance phase for at least 6 months ; * follow-up at Rennes University Hospital ; * patient who has not expressed his opposition to participate in the study. * Exclusion criteria: * Permanent: any cause of modification of the CST unrelated to hemochromatosis (chronic inflammatory disease, excessive consumption of alcohol ...) ; * Temporary: infectious syndrome within 7 days before bleeding.

What they're measuring

Quality of life questionnaire SF 36

Timeframe: Through study completion, an average of 3 months

Biological markers : Transferrin Saturation Coefficient

Timeframe: Through study completion, an average of 3 months

Trial details

NCT IDNCT03356548

SponsorRennes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-04-09

View on ClinicalTrials.gov More Hemochromatoses, Genetic trials